Home › Kanser sa Ovary › California › Baldwin Park
Pag-aaral pangklinika para sa Kanser sa Ovary sa Baldwin Park, CA
Isang pag-aaral para sa Kanser sa Ovary ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Baldwin Park. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
Nagre-recruitPhase 1/2
- Research Site, Duarte · 4 mi ang layo
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Nagre-recruitPhase 1
- City of Hope National Medical Center, Duarte · 4 mi ang layo
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Nagre-recruitPhase 2
- City of Hope - Duarte Cancer Center, Duarte · 4 mi ang layo
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 2
- City of Hope, Duarte · 4 mi ang layo
A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer
Nagre-recruitPhase 1
- City of Hope National Medical Center /ID# 281381, Duarte · 4 mi ang layo
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
Nagre-recruitPhase 1
- Research Site, Duarte · 4 mi ang layo
A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
Nagre-recruitPhase 1/2
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi ang layo
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Nagre-recruitPhase 3
- City of Hope, Duarte, Duarte · 4 mi ang layo
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Nagre-recruitPhase 1
- City of Hope Cancer Center, Duarte · 4 mi ang layo
BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)
Nagre-recruitPhase 1/2
- City of Hope National Medical Center, Duarte · 4 mi ang layo
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
Nagre-recruitPhase 1/2
- City of Hope, Duarte · 4 mi ang layo
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Nagre-recruitPhase 3
- City of Hope Medical Center, Duarte · 4 mi ang layo
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Nagre-recruitPhase 1
- City of Hope, Duarte · 4 mi ang layo
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
Nagre-recruitPhase 3
- City of Hope, Duarte · 4 mi ang layo
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
Nagre-recruitPhase 1
- City of Hope Medical Center, Duarte · 4 mi ang layo
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
Nagre-recruitPhase 1
- City of Hope, Duarte · 4 mi ang layo
A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer
Nagre-recruit
- City of Hope Medical Center, Duarte · 4 mi ang layo
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Nagre-recruit
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi ang layo
AOH1996 for the Treatment of Refractory Solid Tumors
Nagre-recruitPhase 1
- City of Hope Medical Center, Duarte · 4 mi ang layo
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Nagre-recruit
- Beckman Research Institute of City of Hope, Duarte · 4 mi ang layo
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
Nagre-recruitPhase 3
- City of Hope, Duarte · 4 mi ang layo
Safety and Immunogenicity of Innocell Autologous Cellular Immunotherapy for Recurrent Epithelial Ovarian Cancer
Nagre-recruitPhase 1
- City of Hope, Duarte · 4 mi ang layo
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- City of Hope, Duarte · 4 mi ang layo
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
Nagre-recruitPhase 2
- City of Hope National Medical Center, Duarte · 4 mi ang layo
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Duarte · 4 mi ang layo
Pag-aaral para sa Kanser sa Ovary sa ibang lungsod
- Houston, TX89 pag-aaral
- New York City, NY69 pag-aaral
- Boston, MA61 pag-aaral
- Los Angeles, CA50 pag-aaral
- Nashville, TN49 pag-aaral
- Arlington, VA46 pag-aaral
- Philadelphia, PA44 pag-aaral
- Columbus, OH39 pag-aaral
- St. Louis, MO38 pag-aaral
- Chicago, IL36 pag-aaral
- San Antonio, TX31 pag-aaral
- Cleveland, OH30 pag-aaral
Iba pang pag-aaral sa Baldwin Park
- Kanser sa Suso44 pag-aaral
- Acute Myeloid Leukemia40 pag-aaral
- Colorectal Cancer37 pag-aaral
- Non-Small Cell Lung Cancer36 pag-aaral
- Kanser (lahat ng uri)34 pag-aaral
- Kanser sa Prostate30 pag-aaral
- Metastatic Cancer30 pag-aaral
- Myelodysplastic Syndromes26 pag-aaral
- Kanser sa Baga24 pag-aaral
- Multiple Myeloma23 pag-aaral
- Kanser sa Tiyan22 pag-aaral
- Acute Lymphoblastic Leukemia21 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.